Literature DB >> 31120777

The Effect of Cytokine-Stimulation and Pharmacologic Intervention on PGE2 Production in Primary Human Conjunctival and Corneal Cells.

Eisuke Shimizu1, Hiroyuki Yazu1,2, Yoshiyuki Satake3, Kazumi Fukagawa4, Naohiko Aketa1, Dogru Murat1, Naoko Okada2,5, Hiroshi Fujishima2.   

Abstract

We studied the production of PGE2 by human conjunctival and corneal cells in response to inflammation, and reduction of inflammation with non-steroidal anti-inflammatory drugs. Primary cultures of human conjunctival epithelial cells, fibroblasts, corneal epithelial cells, and keratocytes were incubated with IL-4 and TNF-α. PGE2 and COX-2 levels were analyzed. Effects of anti-inflammatory and anti-immune drugs on PGE2 production were also investigated. IL-4 and TNF-α induced the generation of PGE2 and COX-2 in conjunctival and corneal cells. Epithelial PGE2 production was significantly lower than in keratocytes and fibroblasts, which was down-regulated by aspirin. IL-4 and TNF-α enhanced the inflammatory response via prostaglandin production which contributed to ocular surface inflammation. Prostaglandin production was higher in stromal cells than epithelial cells. These results suggest that the epithelial barrier disruption may contribute to ocular allergic inflammation by the PGE2 production from stromal cells. Moreover, NSAIDs were effective in suppressing PGE2 production in our experiment.

Entities:  

Keywords:  Allergic conjunctivitis; FK-506; NSAID; cyclooxygenase; cyclosporine A

Mesh:

Substances:

Year:  2019        PMID: 31120777     DOI: 10.1080/09273948.2019.1595669

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  1 in total

1.  Elevated levels of prostaglandin E2 in the tears of patients with severe allergic conjunctivitis and primary cultured conjunctival cells are suppressed by ketotifen and dexamethasone.

Authors:  Ryutaro Yamanishi; Naoko Okada; Eisuke Shimizu; Hiroshi Fujishima
Journal:  BMJ Open Ophthalmol       Date:  2021-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.